Wednesday, August 17, 2011 4:47:45 PM
The problem is not with the agreement, the problem is with the IMHO absurd use of the term "loan":
RE: "Who else get's paid up front for a "loan?"
There is nothing whatsoever strange about this arrangement: despite the highly misleading usage of the term "loan" (and again, I know it's not you that chose to use that term) what is really happening is that CSC is acting as a broker to sell the shares on the behalf of KBLB and receiving a commission for doing that (in the form of a 20% discount which is pretty standard practice in the market for companies doing secondaries or the equivalent of them (which is what the CSC agreement really is: essentially an ongoing secondary)
I know it's not you that decided to use the term "loan" in that fashion. But standard practice or not, the use of the term "loan" to describe agreements similar to the CSC agreement is inherently misleading in that it uses the term in a way that goes strongly against standard usage.
My point is that the description of the agreement as a "paid up front loan" sounds absurd not because there is anything whatsoever strange about the agreement but because the term "loan" is used in a very strange way that goes strongly against the usual uses of the term.
.
There are a few similarities with a conventional loan (which may be why the term "loan" is sometimes used to describe it): in both the CSC agreement and a conventional loan, something is given as collateral to back up the money and in both the amount of money given is directly related to the value of the collateral.
But the very marked difference is that in a conventional loan the sale of the "collateral" by the lender to recover their money is only as insurance and is not the intended result but a fallback in case of default. In the CSC agreement the sale of the "collateral" is the intended method for the lender to recover their money. Because of that difference the "lender" may sell the "collateral" at any time of its choosing starting immediately after its receipt of it.
We all know that the CSC agreement is not really a loan and we all know what its terms are as they have been discussed repeatedly here in excruciating detail. We are all well aware that CSC is just acting as a broker to sell the shares and is under no obligation to hold them for any length of time. Now did you really fail to realize all that or are you just trying to take advantage of an unusual use of a term to vent your frustration on the company?
RE: "Who else get's paid up front for a "loan?"
There is nothing whatsoever strange about this arrangement: despite the highly misleading usage of the term "loan" (and again, I know it's not you that chose to use that term) what is really happening is that CSC is acting as a broker to sell the shares on the behalf of KBLB and receiving a commission for doing that (in the form of a 20% discount which is pretty standard practice in the market for companies doing secondaries or the equivalent of them (which is what the CSC agreement really is: essentially an ongoing secondary)
I know it's not you that decided to use the term "loan" in that fashion. But standard practice or not, the use of the term "loan" to describe agreements similar to the CSC agreement is inherently misleading in that it uses the term in a way that goes strongly against standard usage.
My point is that the description of the agreement as a "paid up front loan" sounds absurd not because there is anything whatsoever strange about the agreement but because the term "loan" is used in a very strange way that goes strongly against the usual uses of the term.
.
There are a few similarities with a conventional loan (which may be why the term "loan" is sometimes used to describe it): in both the CSC agreement and a conventional loan, something is given as collateral to back up the money and in both the amount of money given is directly related to the value of the collateral.
But the very marked difference is that in a conventional loan the sale of the "collateral" by the lender to recover their money is only as insurance and is not the intended result but a fallback in case of default. In the CSC agreement the sale of the "collateral" is the intended method for the lender to recover their money. Because of that difference the "lender" may sell the "collateral" at any time of its choosing starting immediately after its receipt of it.
We all know that the CSC agreement is not really a loan and we all know what its terms are as they have been discussed repeatedly here in excruciating detail. We are all well aware that CSC is just acting as a broker to sell the shares and is under no obligation to hold them for any length of time. Now did you really fail to realize all that or are you just trying to take advantage of an unusual use of a term to vent your frustration on the company?
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/29/2026 04:15:07 AM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
- Advanced Materials Science 2026: How Spider Silk, Carbon Fiber & Aerogels are Powering Medicine, Defense & Space Tech Today • GlobeNewswire Inc. • 04/14/2026 01:20:00 PM
- From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle • GlobeNewswire Inc. • 04/13/2026 11:05:00 AM
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
